Evidence map›Paper›PMID 38633117›Full record

ArticleEJHaem2024

Montreal cognitive assessment in Brazilian adults with sickle cell disease: The burdens of poor sociocultural background.

Pedro Junqueira Fleury Silva, Caroline Martins Silva, Brunno Machado de Campos, Paula de Melo Campos, Samuel de Souza Medina, Andreza Lamonica, José Vitor Coimbra Trindade, Fernando Cendes, Fernando Ferreira Costa, Sara Teresinha Olalla Saad and 1 more

Open access · diamondAbstract read
In one paragraph

Article in EJHaem, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Pedro Junqueira Fleury SilvaHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
Caroline Martins SilvaHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
Brunno Machado de CamposNeuroimaging Laboratory Department of Neurology University of Campinas (UNICAMP) Campinas Brazil.
Paula de Melo CamposHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
Samuel de Souza MedinaHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
Andreza LamonicaHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
José Vitor Coimbra TrindadeHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
Fernando CendesNeuroimaging Laboratory Department of Neurology University of Campinas (UNICAMP) Campinas Brazil.
Fernando Ferreira CostaHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.
Sara Teresinha Olalla SaadHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.ORCID https://orcid.org/0000-0003-0809-8068
Bruno Deltreggia BenitesHematology and Transfusion Medicine Center University of Campinas (UNICAMP) Campinas Brazil.ORCID https://orcid.org/0000-0003-3985-5690
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease (SCD) patients are at higher risk of developing silent cerebral infarcts and overt stroke, which may reflect cognitive impairment, functional limitations, and worse quality of life. The cognitive function of Brazilian adult SCD patients (

Indexed as

cognitive impairmentMoCAsickle cell diseasesilent cerebral infarcts

Identifiers

PMID38633117
PMCPMC11020111
OpenAlexW4393277405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.